Latest profit margin for Zogenix: -278.39% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2021
Trailing 12 months ending Dec 2021
Zogenix (ZGNX) currently reports a profit margin of -278.39% as of December 2021. That compares with -1534.73% in the prior-year period — up 81.9% year over year. That is below the Healthcare sector average of 14.41%. Use the charts on this page to explore Zogenix's profit margin history and peer comparisons.
Zogenix's profit margin increased from -1534.73% to -278.39% — a 81.9% year-over-year increase (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Zogenix's profit margin of -278.39% is lower than the Healthcare sector average of 14.41%. That is roughly 2031.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Zogenix's current -278.39% should be judged against Healthcare norms (sector average: 14.41%) and against ZGNX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -278.39%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.41%. From there, open related valuation or income-statement pages for Zogenix, and consider following ZGNX for alerts when major investors trade the stock.